Literature DB >> 11326698

The expression of angiopoietins and their receptor Tie-2 in human prostate carcinoma.

J H Wurmbach1, P Hammerer, S Sevinc, H Huland, S Ergün.   

Abstract

BACKGROUND: Angiopoietin-1 and angiopoietin-2 are antagonist angiogenic factors acting via the same receptor Tie-2. Their role in prostate carcinoma (PCa) is not known.
MATERIAL AND METHODS: Using immunohistochemistry, localization of angiopoietin-1, angiopoietin-2 and their receptor Tie-2 was studied in normal human prostate and PCa.
RESULTS: Few epithelial cells of normal prostate expressed angiopoietin-1 and Tie-2 but not angiopoietin-2. Normal prostate blood vessels were negative. In PCa, intraductal grown tumor cells showed angiopoietin-1 but not angiopoietin-2. Blood vessels close to the ducts and some apical tumor cells expressed angiopoietin-1 and Tie-2. In glandular PCa, most of the tumor and intraglandular stromal cells were positive for both angiopoietin-1 and angiopoietin-2. Angiopoietin-1 and angiopoietin-2 were also found in tumor capillaries. Additionally, angiopoietin-2 was expressed in smooth muscle cells of intratumoral blood vessels which also exhibited Tie-2.
CONCLUSIONS: The results presented indicate a role of angiopoietin-Tie-2 system, particularly of angiopoietin-2 in the vascularization of PCa.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11326698

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  11 in total

1.  Serum levels of angiogenic factors and their prognostic relevance in bladder cancer.

Authors:  Tibor Szarvas; Tobias Jäger; Falk Droste; Markus Becker; Ilona Kovalszky; Imre Romics; Süleyman Ergün; Herbert Rübben
Journal:  Pathol Oncol Res       Date:  2008-09-20       Impact factor: 3.201

2.  Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death.

Authors:  Vineet Bhandari; Rayman Choo-Wing; Chun G Lee; Zhou Zhu; Jonathan H Nedrelow; Geoffrey L Chupp; Xucher Zhang; Michael A Matthay; Lorraine B Ware; Robert J Homer; Patty J Lee; Anke Geick; Antonin R de Fougerolles; Jack A Elias
Journal:  Nat Med       Date:  2006-11-05       Impact factor: 53.440

3.  Expression of angiopoietin 1, 2 and their common receptor Tie2 in human gastric carcinoma: implication for angiogenesis.

Authors:  Woo Sung Moon; Ho Sung Park; Ki Hoon Yu; Kyu Yun Jang; Myoung Jae Kang; Harry Park; Andrzej S Tarnawski
Journal:  J Korean Med Sci       Date:  2006-04       Impact factor: 2.153

4.  Expression and significance of angiopoietin-2 in gastric cancer.

Authors:  Xiao-Dong Sun; Xing-E Liu; Jin-Min Wu; Xiu-Jun Cai; Yi-Ping Mou; Jun-Da Li
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

5.  Host-derived angiopoietin-2 affects early stages of tumor development and vessel maturation but is dispensable for later stages of tumor growth.

Authors:  Patrick Nasarre; Markus Thomas; Karoline Kruse; Iris Helfrich; Vivien Wolter; Carleen Deppermann; Dirk Schadendorf; Gavin Thurston; Ulrike Fiedler; Hellmut G Augustin
Journal:  Cancer Res       Date:  2009-02-10       Impact factor: 12.701

6.  Expression of angiopoietin-2 gene in non-small cell lung cancer.

Authors:  Lihua Xing; Zhenxiang Zhang; Yongjian Xu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2003

7.  Autocrine release of angiopoietin-2 mediates cerebrovascular disintegration in Moyamoya disease.

Authors:  Kinga G Blecharz; Dietmar Frey; Tobias Schenkel; Vincent Prinz; Gloria Bedini; Susanne M Krug; Marcus Czabanka; Josephin Wagner; Michael Fromm; Anna Bersano; Peter Vajkoczy
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

8.  Tie-2 regulates the stemness and metastatic properties of prostate cancer cells.

Authors:  Kai-Dun Tang; Boris M Holzapfel; Ji Liu; Terence Kin-Wah Lee; Stephanie Ma; Lidija Jovanovic; Jiyuan An; Pamela J Russell; Judith A Clements; Dietmar W Hutmacher; Ming-Tat Ling
Journal:  Oncotarget       Date:  2016-01-19

9.  A novel angiopoietin-2 selective fully human antibody with potent anti-tumoral and anti-angiogenic efficacy and superior side effect profile compared to Pan-Angiopoietin-1/-2 inhibitors.

Authors:  Markus Thomas; Yvonne Kienast; Werner Scheuer; Monika Bähner; Klaus Kaluza; Christian Gassner; Frank Herting; Ulrich Brinkmann; Stefan Seeber; Anita Kavlie; Martin Welschof; Stefan Ries; K Michael Weidner; Jörg T Regula; Christian Klein
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

10.  Obesity and prostate cancer: gene expression signature of human periprostatic adipose tissue.

Authors:  Ricardo Ribeiro; Cátia Monteiro; Victoria Catalán; Pingzhao Hu; Virgínia Cunha; Amaia Rodríguez; Javier Gómez-Ambrosi; Avelino Fraga; Paulo Príncipe; Carlos Lobato; Francisco Lobo; António Morais; Vitor Silva; José Sanches-Magalhães; Jorge Oliveira; Francisco Pina; Carlos Lopes; Rui Medeiros; Gema Frühbeck
Journal:  BMC Med       Date:  2012-09-25       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.